Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-023215
Filing Date
2019-11-13
Accepted
2019-11-13 16:56:26
Documents
50
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0919_delmarpharma.htm 10-Q 486386
2 CERTIFICATION f10q0919ex31-1_delmar.htm EX-31.1 14365
3 CERTIFICATION f10q0919ex31-2_delmar.htm EX-31.2 14619
4 CERTIFICATION f10q0919ex32-1_delmar.htm EX-32.1 5444
5 CERTIFICATION f10q0919ex32-2_delmar.htm EX-32.2 5607
6 GRAPHIC img_001.jpg GRAPHIC 40026
  Complete submission text file 0001213900-19-023215.txt   3049744

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE dmpi-20190930.xml EX-101.INS 542427
8 XBRL SCHEMA FILE dmpi-20190930.xsd EX-101.SCH 42436
9 XBRL CALCULATION FILE dmpi-20190930_cal.xml EX-101.CAL 32229
10 XBRL DEFINITION FILE dmpi-20190930_def.xml EX-101.DEF 160614
11 XBRL LABEL FILE dmpi-20190930_lab.xml EX-101.LAB 267547
12 XBRL PRESENTATION FILE dmpi-20190930_pre.xml EX-101.PRE 212749
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 191214683
SIC: 2834 Pharmaceutical Preparations